A study for a 69 year old woman who takes Ferrous Fumarate, Lorazepam, Sprycel - from FDA reports


Summary

39 females aged 69 (±5) who take the same drugs are studied. This is a personalized study for a 69 year old female patient who has Anemia, Anxiety, Chronic Myelogenous Leukemia (cml). The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 07, 2017

39 females aged 69 (±5) who take Ferrous Fumarate, Lorazepam, Sprycel are studied.


Number of reports submitted per year:

Ferrous Fumarate, Lorazepam, Sprycel for a 69-year old woman.

Information of the patient in this study:

  • Age: 69
  • Gender: female
  • Conditions: Anemia, Anxiety, Chronic Myelogenous Leukemia (cml)
  • Drugs taken:
    • Ferrous Fumarate (ferrous fumarate)
    • Lorazepam (lorazepam)
    • Sprycel (dasatinib)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Foot, Leg, And Ankle Swelling: 0 (0% of females aged 69 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  • breathing difficulty
  • acute respiratory failure
  • leukocytosis
  • pleural effusion
  • hypokalemia
  • sepsis
  • febrile neutropenia
  • hypoglycemia
  • cardiac failure congestive
  • heart attack
1 - 6 months:
  • breathing difficulty
  • pleural effusion
  • hypokalemia
  • cardiac failure congestive
  • acute respiratory failure
  • hypoglycemia
  • leukocytosis
  • heart attack
  • systolic dysfunction
  • nausea and vomiting
6 - 12 months:
  • weight decreased
  • fatigue
  • pleural effusion
  • nausea
  • high blood pressure
  • headache
1 - 2 years:
n/a
2 - 5 years:
  • pleural infection
  • gastric disorder
  • pleural effusion
  • bronchitis
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • pleural effusion
  • breathing difficulty
  • nausea and vomiting
  • fatigue
  • fever
  • cardiac failure congestive
  • weight decreased
  • high blood pressure
  • weakness
  • acute respiratory failure

Top conditions involved for these people *:

  • Nausea (9 people, 23.08%)
  • Pain (6 people, 15.38%)
  • Nausea And Vomiting (6 people, 15.38%)
  • Constipation (5 people, 12.82%)
  • Lung Cancer - Non-Small Cell (4 people, 10.26%)

Top co-used drugs for these people *:

  • Zofran (8 people, 20.51%)
  • Metoprolol Tartrate (6 people, 15.38%)
  • Aspirin (6 people, 15.38%)
  • Imodium (5 people, 12.82%)
  • Famotidine (5 people, 12.82%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Anxiety, Ferrous fumarate, Lorazepam, Chronic myelogenous leukemia (cml), Sprycel, Foot, leg, and ankle swelling, Anemia

You may be interested in these reviews

More reviews for: Anxiety, Ferrous fumarate, Lorazepam, Chronic myelogenous leukemia (cml), Sprycel, Foot, leg, and ankle swelling, Anemia